Breaking News: 4507 – Market Insights, Analysis & Latest Updates

4507

Earnings call: Shionogi reports revenue dip, optimistic on growth targets

Shionogi & Co. reported a revenue decline but aims for ¥4.6 trillion and ¥1.65 trillion in revenue and profit, focusing on HIV royalties and infectious disease management.

investing.com • 31/10/2024 - 13:04 PM

4507

Japan's Shionogi says Phase 3 study showed COVID pill reduces transmission

Shionogi's Ensitrelvir (Xocova) pill showed efficacy in reducing COVID-19 transmission in a global study, despite earlier trial failures. Japan approved the drug in March.

investing.com • 29/10/2024 - 07:08 AM

Greed and Fear Index

Note: The data is for reference only.

Greed

Earnings call: Shionogi reports revenue dip, optimistic on growth targets

Japan's Shionogi says Phase 3 study showed COVID pill reduces transmission

Currency